納思達(002180.SZ):資產重組事項獲中證監受理
格隆匯5月28日丨納思達(002180.SZ)公佈,公司於2021年5月28日收到中國證監會出具的《中國證監會行政許可申請受理單》(受理序號:211170)。
2021年5月27日,中國證監會對公司提交的《上市公司發行股份購買資產核准》行政許可申請材料進行了受理(發行股份及支付現金購買珠海奔圖電子有限公司100%股權並募集配套資金暨關聯交易的事項),認為該申請材料齊全,符合法定形式。承諾辦結時限為該申請事項自申請受理之日起3個自然月辦結,辦理過程中所需的書面反饋、徵求意見、專家評審、實地核查、重組會、其他等時間不計入辦結時限。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.